Subsets of human CD4+ regulatory T cells express the peripheral homing receptor CXCR3

European Journal of Immunology

Volumn 41, Issue 8, 2011, Pages 2291-2302

  Hoerning, André ^a,b,c   Koss, Kerith ^a,b,c   Datta, Dipak ^a,b,c   Boneschansker, Leonard ^a,b,c   Jones, Caroline N ^c,d   Wong, Ian Y ^c,d   Irimia, Daniel ^c,d   Calzadilla, Katiana ^a,b,c   Benitez, Fanny ^a,b   Hoyer, Peter F ^e   Harmon, William E ^a,b,c   Briscoe, David M ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d SHRINERS HOSPITALS FOR CHILDREN   (United States)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Chemokine receptors; Chemokines; CXCR3; Immunoregulation; Tregs

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOREGULATION; IN VITRO STUDY; KIDNEY TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MICROFLUIDICS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ADULT; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL10; CHILD; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; L-SELECTIN; LYMPHOCYTE ACTIVATION; RECEPTORS, CCR4; RECEPTORS, CXCR3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIROLIMUS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 79960734261     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041095     Document Type: Article

References (53)

1. + regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010. 10: 490-500.
2. +T regulatory cell-mediated suppression. Immunity 2009. 30: 636-645.
3. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E. et al., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001. 27: 20-21.
4. Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J. L., Buist, N., Levy-Lahad, E. et al., X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001. 27: 18-20.
5. +regulatory T cells. Nat. Immunol. 2003. 4: 330-336.
6. +regulatory T cells. Immunol. Rev. 2006. 212: 60-73.
7. +regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 2008. 9: 239-244.
8. +immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
9. Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J. et al., IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 2001. 166: 3789-3796.
10. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. and Powrie, F., An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 1999. 190: 995-1004.
11. + T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA 2003. 100: 10878-10883.
12. Fahlen, L., Read, S., Gorelik, L., Hurst, S. D., Coffman, R. L., Flavell, R. A. and Powrie, F., T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 2005. 201: 737-746.
13. Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R. et al., The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007. 450: 566-569.
14. +T cells. Nat. Immunol. 2007. 8: 1353-1362.
15. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F. et al., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 2007. 204: 1257-1265.
16. Long, E. T., Baker, S., Oliveira, V., Sawitzki, B. and Wood, K. J., Alpha-1, 2-mannosidase and hence N-glycosylation are required for regulatory T cell migration and allograft tolerance in mice. PLoS One 2010. 5: e8894.
17. Nadig, S. N., Wieckiewicz, J., Wu, D. C., Warnecke, G., Zhang, W., Luo, S., Schiopu, A. et al., In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat. Med. 2010. 16: 809-813.
18. Zhang, N., Schroppel, B., Lal, G., Jakubzick, C., Mao, X., Chen, D., Yin, N. et al., Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 2009. 30: 458-469.
19. +regulatory T cells. J. Exp. Med. 2004. 199: 303-313.
20. Huehn, J. and Hamann, A., Homing to suppress: address codes for Treg migration. Trends Immunol. 2005. 26: 632-636.
21. Roncarolo, M. G. and Battaglia, M., Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 2007. 7: 585-598.
22. +regulatory T cells bear functional skin-homing receptors. J. Immunol. 2006. 177: 4488-4494.
23. high regulatory cells in human peripheral blood. J. Immunol. 2001. 167: 1245-1253.
24. +T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 2005. 201: 1037-1044.
25. high regulatory T cells. Blood 2004. 104: 895-903.
26. Baggiolini, M., Chemokines and leukocyte traffic. Nature 1998. 392: 565-568.
27. Lacotte, S., Brun, S., Muller, S. and Dumortier, H., CXCR3, inflammation, and autoimmune diseases. Ann. N. Y. Acad. Sci. 2009. 1173: 310-317.
28. Melter, M., Exeni, A., Reinders, M. E., Fang, J. C., McMahon, G., Ganz, P., Hancock, W. W. and Briscoe, D. M., Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 2001. 104: 2558-2564.
29. Hoffmann, U., Segerer, S., Rummele, P., Kruger, B., Pietrzyk, M., Hofstadter, F., Banas, B. and Kramer, B. K., Expression of the chemokine receptor CXCR3 in human renal allografts - a prospective study. Nephrol. Dial. Transplant. 2006. 21: 1373-1381.
30. Panzer, U., Reinking, R. R., Steinmetz, O. M., Zahner, G., Sudbeck, U., Fehr, S., Pfalzer, B. et al., CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection. Transplantation 2004. 78: 1341-1350.
31. Hancock, W. W., Gao, W., Csizmadia, V., Faia, K. L., Shemmeri, N. and Luster, A. D., Donor-derived IP-10 initiates development of acute allograft rejection. J. Exp. Med. 2001. 193: 975-980.
32. Hancock, W. W., Lu, B., Gao, W., Csizmadia, V., Faia, K., King, J. A., Smiley, S. T. et al., Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 2000. 192: 1515-1520.
33. Tatapudi, R. R., Muthukumar, T., Dadhania, D., Ding, R., Li, B., Sharma, V. K., Lozada-Pastorio, E. et al., Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int. 2004. 65: 2390-2397.
34. Zhao, D. X., Hu, Y., Miller, G. G., Luster, A. D., Mitchell, R. N. and Libby, P., Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J. Immunol. 2002. 169: 1556-1560.
35. Fahmy, N. M., Yamani, M. H., Starling, R. C., Ratliff, N. B., Young, J. B., McCarthy, P. M., Feng, J. et al., Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts. Transplantation 2003. 75: 2044-2047.
36. Hu, H., Aizenstein, B. D., Puchalski, A., Burmania, J. A., Hamawy, M. M. and Knechtle, S. J., Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am. J. Transplant. 2004. 4: 432-437.
37. Hu, H., Kwun, J., Aizenstein, B. D. and Knechtle, S. J., Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation 2009. 87: 1814-1820.
38. Muller, M., Carter, S. L., Hofer, M. J., Manders, P., Getts, D. R., Getts, M. T., Dreykluft, A. et al., CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J. Immunol. 2007. 179: 2774-2786.
39. Hasegawa, H., Inoue, A., Kohno, M., Lei, J., Miyazaki, T., Yoshie, O., Nose, M. and Yasukawa, M., Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model. Gene Ther. 2008. 15: 171-182.
40. Oo, Y. H., Weston, C. J., Lalor, P. F., Curbishley, S. M., Withers, D. R., Reynolds, G. M., Shetty, S. et al., Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J. Immunol. 2010. 184: 2886-2898.
41. Eksteen, B., Miles, A., Curbishley, S. M., Tselepis, C., Grant, A. J., Walker, L. S. and Adams, D. H., Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J. Immunol. 2006. 177: 593-603.
42. -/- mouse recipients. Am. J. Transplant. 2008. 8: 1593-1603.
43. Sporici, R. and Issekutz, T. B., CXCR3 blockade inhibits T-cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, disease. Eur. J. Immunol. 2010. 40: 2751-2761.
44. Read, S., Malmstrom, V. and Powrie, F., Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 2000. 192: 295-302.
45. Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B. and Campbell, D. J., The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 2009. 10: 595-602.
46. Butler, K. L., Ambravaneswaran, V., Agrawal, N., Bilodeau, M., Toner, M., Tompkins, R. G., Fagan, S. and Irimia, D., Burn injury reduces neutrophil directional migration speed in microfluidic devices. PLoS One 2010. 5: e11921.
47. +T cells. Blood 2008. 111: 453-462.
48. Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F. et al., The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 2009. 30: 832-844.
49. Harmon, W., Meyers, K., Ingelfinger, J., McDonald, R., McIntosh, M., Ho, M., Spaneas, L. et al., Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation. J. Am. Soc. Nephrol. 2006. 17: 1735-1745.
50. Muthukumar, T., Dadhania, D., Ding, R., Snopkowski, C., Naqvi, R., Lee, J. B., Hartono, C. et al., Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N. Engl. J. Med. 2005. 353: 2342-2351.
51. +regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis. Am. J. Pathol. 2010. 177: 464-472.
52. Gao, W., Lu, Y., El Essawy, B., Oukka, M., Kuchroo, V. K. and Strom, T. B., Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am. J. Transplant. 2007. 7: 1722-1732.
53. Bestard, O., Cruzado, J. M. and Grinyo, J. M., Inhibitors of the mammalian target of rapamycin and transplant tolerance. Transplantation 2009. 87: S27-S29.